Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Smith

Showing results (581-590 of 594) with videos related to

Pageof 60
Sort By:
Nature Communications|May 3, 2022
Indigenous oyster fisheries persisted for millennia and should inform future managementLeslie Reeder-Myers, Todd J Braje, Courtney A Hofman, et al.
The New England Journal of Medicine|March 5, 2020
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 InfectionChloe Orkin, Keikawus Arasteh, Miguel Górgolas Hernández-Mora, et al.
The New England Journal of Medicine|March 5, 2020
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 SuppressionSusan Swindells, Jaime-Federico Andrade-Villanueva, Gary J Richmond, et al.
The Lancet. HIV|April 1, 2021
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR studyChloe Orkin, Shinichi Oka, Patrick Philibert, et al.
Nature|November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysDan H Barouch, James B Whitney, Brian Moldt, et al.
Lancet (London, England)|December 14, 2020
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority studyEdgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.
BMC Geriatrics|January 3, 2024
Transitions of care for older adults discharged home from the emergency department: an inductive thematic content analysis of patient commentsVanessa Couture, Nathalie Germain, Émilie Côté, et al.
Nature|July 22, 2014
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeysJames B Whitney, Alison L Hill, Srisowmya Sanisetty, et al.
Journal of Neurology|January 15, 2025
MOG antibody-associated disease epidemiology in Olmsted County, USA, and MartiniqueLaura Cacciaguerra, Elia Sechi, Isabelle Komla-Soukha, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 2, 2020
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR TrialsGiuliano Rizzardini, Edgar T Overton, Chloe Orkin, et al.
Pageof 60

Showing results (581-590 of 594) with videos related to

Sort By:
Pageof 60
Nature Communications|May 3, 2022
Indigenous oyster fisheries persisted for millennia and should inform future managementLeslie Reeder-Myers, Todd J Braje, Courtney A Hofman, et al.
The New England Journal of Medicine|March 5, 2020
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 InfectionChloe Orkin, Keikawus Arasteh, Miguel Górgolas Hernández-Mora, et al.
The New England Journal of Medicine|March 5, 2020
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 SuppressionSusan Swindells, Jaime-Federico Andrade-Villanueva, Gary J Richmond, et al.
The Lancet. HIV|April 1, 2021
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR studyChloe Orkin, Shinichi Oka, Patrick Philibert, et al.
Nature|November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysDan H Barouch, James B Whitney, Brian Moldt, et al.
Lancet (London, England)|December 14, 2020
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority studyEdgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.
BMC Geriatrics|January 3, 2024
Transitions of care for older adults discharged home from the emergency department: an inductive thematic content analysis of patient commentsVanessa Couture, Nathalie Germain, Émilie Côté, et al.
Nature|July 22, 2014
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeysJames B Whitney, Alison L Hill, Srisowmya Sanisetty, et al.
Journal of Neurology|January 15, 2025
MOG antibody-associated disease epidemiology in Olmsted County, USA, and MartiniqueLaura Cacciaguerra, Elia Sechi, Isabelle Komla-Soukha, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 2, 2020
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR TrialsGiuliano Rizzardini, Edgar T Overton, Chloe Orkin, et al.
Pageof 60